Cargando…

CircLATS2 Regulates miR-520a-3p/E2F7/p-VEGFR2 Signaling Pathway to Promote Hepatocellular Carcinoma Progression and Angiogenesis

OBJECTIVE: To investigate the effect of circLATS2 on the progression and angiogenesis of hepatocellular carcinoma and its molecular mechanism. METHODS: The expression of circLATS2 in hepatocellular carcinoma was detected by qRT-PCR. The StarBase database was used to predict the potential miRNA, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yefeng, Yuan, Jianmao, Tu, Zhengbin, Chen, Huahua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015858/ https://www.ncbi.nlm.nih.gov/pubmed/35444695 http://dx.doi.org/10.1155/2022/3744560

Ejemplares similares

Circlator: automated circularization of genome assemblies using long sequencing reads
por: Hunt, Martin, et al.
Publicado: (2015)

MiR-93 enhances angiogenesis and metastasis by targeting LATS2
por: Fang, Ling, et al.
Publicado: (2012)

A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis
por: Azad, T., et al.
Publicado: (2018)

CircCRIM1 Ameliorates Endothelial Cell Angiogenesis in Aging through the miR-455-3p/Twist1/VEGFR2 Signaling Axis
por: Zhao, Lei, et al.
Publicado: (2022)

circKCNN2 suppresses the recurrence of hepatocellular carcinoma at least partially via regulating miR‐520c‐3p/methyl‐DNA‐binding domain protein 2 axis
por: Liu, Donghong, et al.
Publicado: (2022)

Largazole Inhibits Ocular Angiogenesis by Modulating the Expression of VEGFR2 and p21
por: Qiu, Beiying, et al.
Publicado: (2021)

MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2
por: Ghosh, Alip, et al.
Publicado: (2017)

CircAGFG1 Promotes Osteosarcoma Progression and Stemness by Competing with miR-302a-3p to Upregulate the Expression of LATS2
por: Li, Tongchun, et al.
Publicado: (2022)

Rutacecarpine Inhibits Angiogenesis by Targeting the VEGFR2 and VEGFR2-Mediated Akt/mTOR/p70s6k Signaling Pathway
por: Ji, Lijun, et al.
Publicado: (2018)

Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis
por: Liu, Hua, et al.
Publicado: (2021)

miR-25-3p promotes endothelial cell angiogenesis in aging mice via TULA-2/SYK/VEGFR-2 downregulation
por: Lian, Chong, et al.
Publicado: (2020)

Retraction of “Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis”
por: Liu, Hua, et al.
Publicado: (2022)

Inhibition of VEGF(165)/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis
por: Chen, Chi-Kuan, et al.
Publicado: (2016)

Circular RNA circ_103820 suppresses lung cancer tumorigenesis by sponging miR-200b-3p to release LATS2 and SOCS6
por: Chi, Yongbin, et al.
Publicado: (2021)

CircCRIM1 Promotes Hepatocellular Carcinoma Proliferation and Angiogenesis by Sponging miR-378a-3p and Regulating SKP2 Expression
por: Ji, Yang, et al.
Publicado: (2021)

LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma
por: Teng, Fei, et al.
Publicado: (2020)

miR-103 promotes the metastasis and EMT of hepatocellular carcinoma by directly inhibiting LATS2
por: Han, Li-Li, et al.
Publicado: (2018)

Exosomal lncRNA RAMP2-AS1 Derived from Chondrosarcoma Cells Promotes Angiogenesis Through miR-2355-5p/VEGFR2 Axis
por: Cheng, Cheng, et al.
Publicado: (2020)

VEGF-dependent tumor angiogenesis requires the inverse and reciprocal regulation of VEGFR1 and VEGFR2
por: Zhang, Zhaocheng, et al.
Publicado: (2009)

VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis
por: D'Haene, Nicky, et al.
Publicado: (2013)

Computational Modeling to Quantify the Contributions of VEGFR1, VEGFR2, and Lateral Inhibition in Sprouting Angiogenesis
por: Kühn, Clemens, et al.
Publicado: (2019)

The P-type ATPase transporter ATP7A promotes angiogenesis by limiting autophagic degradation of VEGFR2
por: Ash, Dipankar, et al.
Publicado: (2021)

High circ-SEC31A expression predicts unfavorable prognoses in non-small cell lung cancer by regulating the miR-520a-5p/GOT-2 axis
por: Jin, Mingming, et al.
Publicado: (2020)

FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer
por: Hsu, Hsi-Hsien, et al.
Publicado: (2019)

Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2
por: Tu, Yingfeng, et al.
Publicado: (2015)

Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma
por: Teng, Fei, et al.
Publicado: (2020)

Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway
por: Li, Jia, et al.
Publicado: (2019)

Endophilin-A2 dependent VEGFR2 endocytosis promotes sprouting angiogenesis
por: Genet, Gael, et al.
Publicado: (2019)

Circular RNA 0102049 suppresses the progression of osteosarcoma through modulating miR-520g-3p/PLK2 axis
por: Zhang, Xianliao, et al.
Publicado: (2021)

Hsa_circ_0088212-mediated miR-520 h/APOA1 axis inhibits osteosarcoma progression
por: Liu, Feng, et al.
Publicado: (2021)

Corrigendum: Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2
por: Tu, Yingfeng, et al.
Publicado: (2016)

Circular RNA Circ100084 functions as sponge of miR-23a-5p to regulate IGF2 expression in hepatocellular carcinoma
por: Yang, Jie, et al.
Publicado: (2020)

Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and ‐LAT2, and LAT1 and LAT2 Substrates and Inhibitors
por: Kantipudi, Satish, et al.
Publicado: (2021)

P18 peptide, a functional fragment of pigment epithelial-derived factor, inhibits angiogenesis in hepatocellular carcinoma via modulating VEGF/VEGFR2 signalling pathway
por: Wang, Xin, et al.
Publicado: (2017)

Quinazoline derivative compound (11d) as a novel angiogenesis inhibitor inhibiting VEGFR2 and blocking VEGFR2-mediated Akt/mTOR /p70s6k signaling pathway
por: Li, Zeng, et al.
Publicado: (2016)

SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis
por: Zhou, Huanjiao Jenny, et al.
Publicado: (2018)

Sialyllactose suppresses angiogenesis by inhibiting VEGFR-2 activation, and tumor progression
por: Chung, Tae-Wook, et al.
Publicado: (2017)

TIPE regulates VEGFR2 expression and promotes angiogenesis in colorectal cancer
por: Zhong, Mengya, et al.
Publicado: (2020)

Tetraspanin18 regulates angiogenesis through VEGFR2 and Notch pathways
por: Li, Grace X., et al.
Publicado: (2021)

Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
por: Jiang, Zongru, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vgps6ru65994g9d8qri5hjhjep